Skip to content

Impact of phlebotomy on steatohepatitis

Study of phlebotomy efficacy in improvement of liver fibrosis and its function among patients with non alcoholic steatohepatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161205031252N4
Enrollment
40
Registered
2017-12-06
Start date
2017-07-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic steatohepatitis (NASH). Other specified inflammatory liver diseases

Interventions

Intervention 1: Intervention group: Phlebotomy at first and fifth months, (with a needle and a blood transfusion bag, 400 cc each time from the median cubital vein) with routine treatment. Interventio
Treatment - Other
Intervention group: Phlebotomy at first and fifth months, (with a needle and a blood transfusion bag, 400 cc each time from the median cubital vein) with routine treatment

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: age between 18-65 years proven steatohepatitis with sonography or fibro scan Hb more than 13 in men and more than 12 in women Informed consent

Exclusion criteria

Exclusion criteria: any other liver disease history of alcohol use (more than 10gr daily for women and more than 20gr daily for men) pregnant and lactating women women in childbearing age with no reliable Contraception method weight under 50kg uncontrolled underlying disease contraindication of vitamin E use

Design outcomes

Primary

MeasureTime frame
Liver fibrosis. Timepoint: before intervention and after 6 month. Method of measurement: fibroscan.;Liver function. Timepoint: before intervention and after 6 month. Method of measurement: Blood samples laboratory study.

Secondary

MeasureTime frame
Ferritin level. Timepoint: at the begining of study and 6 months later. Method of measurement: Laboratory blood level measurement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Hormati

Ghoum University of Medical Sciences

hormatia@yahoo.com+98 25 3612 2053

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026